NCT01275599
Collaborator, Phase 1, Completed, 16 people, Jan 12, 2011
A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female Volunteers
Phase 1, Completed, 20 people, Dec 31, 2010
A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients
Phase 2, Completed, 54 people, Sep 13, 2010
NCT00993148
Collaborator, Phase 2, Completed, 25 people, Oct 12, 2009
NCT00933283
Phase 1, Completed, 18 people, Jul 7, 2009
VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram
Phase 1, Completed, 16 people, Jul 7, 2009
VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer
Phase 1, Completed, 20 people, Jan 26, 2009
VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.
Phase 1, Completed, 40 people, Oct 17, 2008
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
Phase 4, Completed, 68 people, Sep 23, 2008
NCT00703118
Phase 3, Completed, 663 people, Jun 23, 2008
NCT00580801
Phase 2, Completed, 24 people, Dec 27, 2007
NCT00561015
Phase 2, Completed, 52 people, Nov 20, 2007
NCT00535847
Collaborator, Phase 2, Completed, 117 people, Sep 26, 2007
A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).
Phase 2, Completed, 23 people, Sep 24, 2007
NCT00528528
Phase 2, Completed, 166 people, Sep 12, 2007
Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.
Phase 3, Completed, 10 people, Apr 16, 2007
GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.
Phase 3, Completed, 429 people, Sep 27, 2006